- Filed
- Feb 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Jan 30, 2026 | 139.32M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 142.93M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 141.35M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 135.74M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 128.75M sh |
| Stock Repurchased | Q3 2026 · Dec 31, 2025 | $1.85M |
| Stock Repurchased | Q3 2026 · Dec 31, 2024 | $0 |
| Capex | Q3 2026 · Dec 31, 2025 | $3.1M |
| Capex | Q3 2026 · Dec 31, 2024 | $2.05M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | $41.4M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | $57.68M |
| Long Term Debt | Q3 2026 · Dec 31, 2025 | $294.47M |
| Long Term Debt | Q3 2026 · Mar 31, 2025 | $338.37M |
| Short Term Debt | Q3 2026 · Dec 31, 2025 | $26.7M |
| Short Term Debt | Q3 2026 · Mar 31, 2025 | $11.59M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $86.88M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $88.05M |
| Cash And Equivalents restated | Q3 2026 · Dec 31, 2024 | $104.2M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $142.86M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $133.16M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $128.19M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $122.2M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $113.01M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $109.81M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $104.59M |
| Stockholders Equity | Q3 2026 · Mar 31, 2024 | $101.96M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $179.94M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $169.24M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $518.66M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $560.97M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $203.88M |
| Current Assets | Q3 2026 · Mar 31, 2025 | $203.87M |
| Total Assets | Q3 2026 · Dec 31, 2025 | $661.52M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $683.18M |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $0.04 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $0.01 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $0.02 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | −$0.17 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $0.04 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $0.01 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $0.02 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | −$0.17 |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $27.19M |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $83.47M |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $29.83M |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $93.26M |
| Net Income | Q3 2026 · Dec 31, 2025 | $5.09M |
| Net Income | Q3 2026 · Dec 31, 2025 | $1.54M |
| Net Income | Q3 2026 · Sep 30, 2025 | $767K |
| Net Income | Q3 2026 · Jun 30, 2025 | −$4.32M |
| Net Income | Q3 2026 · Dec 31, 2024 | $3.02M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$21.81M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$14.54M |
| Net Income | Q3 2026 · Jun 30, 2024 | −$10.29M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $9.69M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $15.61M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $8.98M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $14.77M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $118.22M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $358M |
| Gross Profit | Q3 2026 · Dec 31, 2024 | $121.09M |
| Gross Profit | Q3 2026 · Dec 31, 2024 | $365.22M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $66.83M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $192.51M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $57.8M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $172.81M |
| Revenue | Q3 2026 · Dec 31, 2025 | $185.05M |
| Revenue | Q3 2026 · Dec 31, 2025 | $550.51M |
| Revenue | Q3 2026 · Dec 31, 2024 | $178.88M |
| Revenue | Q3 2026 · Dec 31, 2024 | $538.03M |